Results of a Screening Study of Tumor Markers (REA, CA 19-9, PSA, CA15-3) among the Population in South Yakutia

被引：0
|
作者：
Antipina, Ulyana D. [1 ]
Markova, Sardana, V [1 ]
Borisova, Natalia, V [1 ]
Alekseeva, Sardana N. [1 ]
Malogulova, Irina Sh [1 ]
Sivtseva, Tyuaara P. [1 ]
Yadrikhinskaya, Vera N. [1 ]
Yadrikhinskaya, Evgenia E. [1 ]
机构：
[1] MK Ammosov North Eastern Fed Univ, The Republic Of Sakha, Yakutia, Russia
来源：
INTERNATIONAL JOURNAL OF BIOMEDICINE | 2019年 / 9卷 / 03期
关键词：
cancer; pathology; oncology; screening research; damage; CLINICAL UTILITY; DIAGNOSIS; ANTIGEN; CANCER; SERUM;
D O I：
10.21103/Article9(3)_OA6
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Early cancer screening is the most effective way to reduce cancer mortality. The number of potentially viable tumor markers (TMs) is rapidly expanding and promises further improvement in sensitivity and specificity. The article presents the results of a population-based study of screening for the most common types of cancer in individuals living in South Yakutia.
引用
收藏
页码：220 / 222
页数：3
相关论文
共 50 条
  • [1] Screening asymptomatic population for cancer by measuring serum PSA, CEA, AFP, CA 19-9, CA 125 and CA 15-3: Taiwan experience.
    Tsao, K
    Sun, C
    Wu, JT
    CLINICAL CHEMISTRY, 2000, 46 (06) : A162 - A162
  • [2] TUMOR-MARKERS CA 19-9, CA 125, CA 72-4 AND CA 50 IN PATHOLOGY OF NEOPLASIA - RESULTS OF A 3-YEAR STUDY
    FRATTA, M
    CIOFFI, M
    DELUCIA, D
    BRESCIANI, F
    JOURNAL OF NUCLEAR MEDICINE AND ALLIED SCIENCES, 1990, 34 (04): : 285 - 288
  • [3] The utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis
    Tasci, Canturk
    Ozkaya, Sevket
    Ozkara, Bikemgul
    Tozkoparan, Ergun
    Ozkan, Metin
    Karadurmus, Nuri
    Serdar, Muhittin
    Balkan, Arzu
    Bilgic, Hayati
    ONCOTARGETS AND THERAPY, 2012, 5 : 385 - 390
  • [4] BETWEEN-LAB AGREEMENT FOR THE TUMOR-MARKERS TPA, CA19-9, CA125, CA15-3 OBSERVED IN A MULTICENTER STUDY
    PILO, A
    ZUCCHELLI, GC
    CHIESA, MR
    MASINI, S
    CLINICAL CHEMISTRY, 1988, 34 (06) : 1298 - 1299
  • [5] Cation-exchange antibody labeling for simultaneous electrochemical detection of tumor markers CA15-3 and CA19-9
    Wang, Guangjie
    Qing, Yi
    Shan, Jinlu
    Jin, Feng
    Yuan, Ruo
    Wang, Dong
    MICROCHIMICA ACTA, 2013, 180 (7-8) : 651 - 657
  • [6] Cation-exchange antibody labeling for simultaneous electrochemical detection of tumor markers CA15-3 and CA19-9
    Guangjie Wang
    Yi Qing
    Jinlu Shan
    Feng Jin
    Ruo Yuan
    Dong Wang
    Microchimica Acta, 2013, 180 : 651 - 657
  • [7] IMMUNOHISTOCHEMICAL STUDY OF CA19-9, CEA AND CA15-3 IN GALLBLADDER LESIONS
    KIJIMA, H
    OSAMURA, RY
    WATANABE, K
    ISHIHARA, N
    WATANABE, H
    JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 1990, 38 (07) : 1064 - 1064
  • [8] DATA BASED PREDICTION OF CLASSIFICATION OF TUMOR MARKERS AFP, CA-125, CA15-3, CEA, CYFRA, and PSA
    Winkler, S. M.
    Affenzeller, M.
    Jacak, W.
    Stekel, H.
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2011, 49 : S274 - S274
  • [9] Determination of CA 19-9 and CA 15-3 on Elecsys® 2010 immunoanalyzers -: Results of a field study.
    Domke, I
    Stieber, P
    van Helden, J
    Friese, S
    van Kamp, GJ
    Roth, HJ
    Troalen, F
    Weisbrich, C
    Wollenberg, P
    CLINICAL CHEMISTRY, 1999, 45 (06) : A109 - A109
  • [10] Longitudinal evaluation of external quality assessment results for CA 15-3, CA 19-9, and CA 125
    Kremser, Marcel
    Weiss, Nathalie
    Kaufmann-Stoeck, Anne
    Vierbaum, Laura
    Schmitz, Arthur
    Schellenberg, Ingo
    Holdenrieder, Stefan
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2024, 11
12345